The Brain-Insulin Connection

How Metabolic Health Shapes Lifelong Cognitive Vitality

Metabolic Health Series | Issue 10

Of all the long-term consequences of metabolic dysfunction, the one that concerns me most — and that is most underappreciated in mainstream health conversations — is what happens to the brain.

We talk about the heart, the liver, the pancreas. We talk about weight and blood sugar and triglycerides. But the brain is, in many ways, the organ most acutely sensitive to metabolic disruption — and the one where the consequences of chronic insulin resistance and poor metabolic health play out over the longest timeline, often beginning decades before any symptoms appear.

This issue is built around the work of Lisa Mosconi — neuroscientist, director of the Women's Brain Initiative at Weill Cornell Medicine, and the researcher perhaps most responsible for bringing the brain-metabolism connection out of the lab and into the public conversation.

The Brain Is a Metabolic Organ

The brain represents roughly 2% of body weight but consumes approximately 20% of the body's total energy. It is the most metabolically demanding organ in the body — and it is exquisitely sensitive to the quality and consistency of its fuel supply.

Under normal conditions, the brain runs primarily on glucose. But it doesn't simply absorb glucose passively — it depends on a very precise insulin signaling system to regulate that glucose uptake. When insulin resistance develops in the brain — when neurons stop responding to insulin the way they should — glucose uptake falls, energy production falters, and the brain begins to operate in a state of chronic fuel deficit.

Researchers can actually see this happening using a brain scan called FDG PET (fluorodeoxyglucose positron emission tomography). Think of it as a fuel gauge for the brain — it shows how much energy different regions are using in real time. What these scans have revealed is remarkable: the brain's energy use starts dropping decades before any Alzheimer's symptoms appear. This suggests a metabolic decline isn't a side effect of the disease — it may be one of its earliest causes. In other words, changes in brain fuel use can show up twenty or more years before a diagnosis.

"Type 3 Diabetes" — The Insulin-Alzheimer's Connection

The term "type 3 diabetes" was proposed by researchers to describe Alzheimer's disease as a condition of brain-specific insulin resistance — a state in which the brain's cells lose their sensitivity to insulin, with consequences strikingly parallel to what happens in the rest of the body during type 2 diabetes.

The concept is controversial in some clinical circles — Alzheimer's is a complex, multifactorial disease — but the metabolic evidence supporting it is substantial. Insulin receptors are distributed throughout the brain, particularly in regions critical for memory and learning, including the hippocampus. Insulin in the brain is not primarily about glucose management: it plays a key role in synaptic plasticity, neurotransmitter regulation, neuronal survival, and the clearance of amyloid-beta — the protein that accumulates in Alzheimer's plaques. When brain insulin signaling is impaired, all of these functions are compromised.

One of the main features of Alzheimer's disease is a severe reduction of the cerebral metabolic rate for glucose, with an increasing body of evidence indicating a deficient or altered energy metabolism that changes the overall oxidative microenvironment for neurons during the pathogenesis and progression of Alzheimer’s.

People with type 2 diabetes have approximately double the risk of developing Alzheimer's disease compared to those without it. The mechanisms overlap significantly — chronic hyperinsulinemia, oxidative stress, inflammation, and impaired mitochondrial function are common to both conditions. The metabolic interventions that address type 2 diabetes — reducing refined carbohydrates, improving insulin sensitivity, protecting sleep, managing cortisol — are also, by extension, among the most evidence-based strategies available for Alzheimer's prevention.

The Female Brain: A Distinct and Urgent Story

Here is where Mosconi's research becomes particularly urgent — and where this issue connects directly to the midlife women's health conversation from Issue 3.

Nearly two-thirds of all Alzheimer's patients are women, most of them postmenopausal. While sex differences in AD have historically been attributed to women's relative longevity, accumulating evidence challenges that view, pointing to female sex-specific biological underpinnings.

Mosconi's PET imaging studies — comparing hundreds of men and women at the same age — have produced striking findings. In a study of more than 120 participants, menopausal status was the main factor contributing to higher beta-amyloid levels, lower glucose metabolism, and lower gray matter and white matter volumes in women. Women in their 40s and 50s — cognitively normal, with no symptoms — were already showing measurable Alzheimer's-related brain changes that their male counterparts were not.

Using PET brain imaging, Mosconi's team demonstrated that the ebb in estrogen causes the loss of a key neuroprotective element in the female brain, with an aggressively higher vulnerability to brain aging and Alzheimer's disease.

Estrogen is not just a reproductive hormone but also a powerful neuroprotective hormone that protects the brain, promotes blood flow, and supports synaptic function. During menopause, women lose this protection — which may explain why women have twice the risk of developing Alzheimer's compared to men.

This is not a reason for alarm. It is a reason for action — specifically, early action. Mosconi has spent decades building the science that shows Alzheimer's risk in women is neither inevitable nor untreatable, and that the choices women make in midlife around hormones, sleep, and nutrition have a direct, and measurable, impact on the brain's long-term health.

Midlife, it turns out, is the most critical window for neuroprotective intervention — not because it's too late, but because the brain's metabolic trajectory is still highly responsive to the inputs it receives.

The Glymphatic System: Why Sleep Protects the Brain

Sleep's role in metabolic health was covered in Issue 7 — but there is a brain-specific dimension to sleep that deserves its own moment here.

During deep sleep, the brain activates the glymphatic system — a fluid-clearance network, discovered relatively recently, that functions as the brain's overnight waste removal system. Cerebrospinal fluid flows through channels surrounding blood vessels, flushing out metabolic waste products accumulated during waking hours. Among the most significant of those waste products: amyloid-beta and tau — the proteins most associated with Alzheimer's pathology.

In other words, deep sleep is not just restorative for the body. It is when the brain literally cleans itself. Chronic sleep deprivation — of the kind that characterizes millions of modern adults — impairs glymphatic clearance, allowing amyloid and tau to accumulate over time. This is one of the most compelling biological arguments for treating sleep as a non-negotiable neuroprotective practice, not a lifestyle convenience.

The metabolic-sleep-brain triad closes the loop: metabolic dysfunction impairs sleep quality, impaired sleep reduces glymphatic clearance, and reduced glymphatic clearance accelerates Alzheimer's pathology. Each link in that chain is also a point of intervention.

What Neuroprotective Nutrition Actually Looks Like

The most evidence-based dietary approach for brain protection is not dramatically different from the metabolic nutrition framework outlined in Issue 5 — which is exactly the point. The same dietary principles that protect the heart, liver, and pancreas also protect the brain. But the brain has some specific nutritional requirements worth naming explicitly.

The Mediterranean and MIND diets have the strongest evidence base for cognitive protection. You know the Mediterranean diet from Issue 5 — the MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) is its brain-focused cousin, developed at Rush University from research on which foods most protect cognition. It emphasizes leafy greens, berries, nuts, beans, whole grains, fish, poultry, and olive oil, while limiting red meat, butter, cheese, sweets, and fried food. Berries stand out in particular — blueberries and strawberries are among the most consistently protective single foods identified to date.

A five-year study of 1,500 participants found that higher adherence to both diets was associated with better cognitive function, less brain shrinkage, lower levels of Alzheimer's-related proteins (amyloid-beta and tau), and reduced inflammation — with the MIND diet showing a slight edge over the Mediterranean diet alone. And you don't need to be perfect: research shows that eating more of the brain-healthy foods and less of the limited ones, most days, is enough to see real benefit.

DHA — the long-chain omega-3 fatty acid found in fatty fish — deserves special mention. DHA is a primary structural component of brain cell membranes and is essential for synaptic function. A majority of available studies suggest that consumption of long-chain omega-3 fatty acids from fish or fish oil exerts positive effects on brain health and cognition in older humans. Two to three servings of fatty fish per week — salmon, sardines, mackerel, anchovies — is among the most consistently supported neuroprotective dietary habits.

Polyphenols protect the brain through multiple pathways: Mediterranean and MIND diets lower dementia risk and enhance cognitive resilience, likely due to the combined effects of polyphenols, omega-3 fatty acids, and antioxidants. Extra virgin olive oil — rich in oleocanthal and oleuropein — has specific anti-amyloid properties. Berries, particularly blueberries, have among the strongest evidence for cognitive protection of any single food. Dark leafy greens, cruciferous vegetables, and deeply pigmented fruits deliver the diversity of polyphenols that the brain's antioxidant systems depend on.

B vitamins — particularly B6, B12, and folate — are essential for homocysteine metabolism. Elevated homocysteine is an independent risk factor for dementia and cognitive decline, and inadequate B vitamin status is common in older adults. Both the Mediterranean and MIND diets promote B vitamin intake through their emphasis on fish, legumes, whole grains, nuts, seeds, and vegetables.

Blood sugar stability is as neuroprotective as any specific food. Chronically elevated blood glucose and insulin produce oxidative stress, glycation of brain proteins, and neuroinflammation — all of which accelerate cognitive aging. The dietary principles from Issues 2 and 5 — reducing refined carbohydrates, prioritizing fiber and protein, maintaining a compressed eating window — are directly neuroprotective when practiced consistently over time.

The Lifestyle Trifecta for Brain Protection

The nutritional piece is essential, but Mosconi is emphatic that diet is one part of a three-part brain protection framework:

Sleep. As described above, deep sleep is the brain's most powerful restorative and cleansing mechanism. Seven to nine hours of quality sleep, consistently protected, is non-negotiable for long-term neuroprotection.

Movement. Aerobic exercise increases cerebral blood flow, stimulates the production of BDNF (brain-derived neurotrophic factor — sometimes described as "fertilizer for the brain"), and improves insulin sensitivity in brain tissue. Both Zone 2 cardio and resistance training have been shown to reduce Alzheimer's risk markers. The Norwegian 4x4 HIIT protocol discussed in Issues 4 and 6 produces cardiovascular adaptations that directly benefit brain perfusion.

Stress regulation. Chronic cortisol elevation damages the hippocampus — the brain's primary memory center — directly. The nervous system regulation practices discussed in Issue 9 are, therefore, also neuroprotective practices. Breathwork, somatic movement, nature exposure, and genuine rest are not supplementary brain health habits – they are among the most direct interventions available.

A Note on Testing

For those who want to understand their current brain metabolic trajectory, several tools are becoming more accessible:

ApoE genotyping — a genetic test available through functional medicine practitioners — identifies whether you carry the ApoE4 allele, which is the strongest known genetic risk factor for late-onset Alzheimer's. Carrying one copy approximately triples risk; carrying two copies increases it tenfold. Knowing this enables more targeted preventive action — it is information, not a sentence.

Homocysteine — available through standard blood testing — is a valuable and underutilized marker of both B vitamin status and neuroinflammatory risk.

Fasting insulin and HOMA-IR — already discussed throughout this series — are among the most predictive metabolic markers for long-term brain health.

Three Things to Do This Week

  1. Eat fatty fish twice this week. Salmon, sardines, mackerel, or anchovies — prepared simply, with olive oil and greens. You are feeding your brain's structural needs directly.

  2. Prioritize one night of exceptional sleep. Choose one night this week to go to bed 45 minutes earlier than usual, make the room cool and dark, and do a five-minute breathwork wind-down before sleep. Notice the difference in mental clarity the following morning.

  3. Add one deeply colored polyphenol food daily. A handful of blueberries, a drizzle of high-quality extra virgin olive oil, a cup of green tea, a serving of dark leafy greens. These small, consistent additions build the neuroprotective nutritional foundation over time.

Next issue: "The Gut-Metabolism Axis" — how your microbiome shapes blood sugar, inflammation, and cognitive health, and the dietary habits that rebuild a metabolic-supportive gut ecosystem.

This newsletter is educational and does not constitute medical advice. 

I’d love to know what you’re doing to protect your brain?

Drop me a line and let me know.


About Lisa Marlene Thompson - Functional Nutritionist FNTP

Lisa Marlene Thompson is a Functional Nutritional Therapy Practitioner, somatic facilitator, and health and lifestyle guide for anyone ready to feel more alive in their body. With advanced certifications in menopause science with Dr. Stacy Sims, somatic movement with Michaela Boehm, and sleep and brain health informed by the research of Lisa Mosconi and Matt Walker, her work sits at the intersection of cutting-edge science and deep body wisdom.

Her signature program — Strength, Sleep & Sensuality — is an invitation to come home to your body: to build real strength, reclaim restorative sleep, and rediscover a nervous system that is grounded and provides aliveness in the body that belongs to this chapter of life. She is based in Los Angeles and works with clients worldwide.

Your most vibrant chapter is still ahead.

I'd love to explore what's possible together → Reach out: lisa@lisamarlenethompson.com